66 related articles for article (PubMed ID: 25856400)
21. Cellular trajectories of peptide-modified gold particle complexes: comparison of nuclear localization signals and peptide transduction domains.
Tkachenko AG; Xie H; Liu Y; Coleman D; Ryan J; Glomm WR; Shipton MK; Franzen S; Feldheim DL
Bioconjug Chem; 2004; 15(3):482-90. PubMed ID: 15149175
[TBL] [Abstract][Full Text] [Related]
22. Cell-penetrating cis-gamma-amino-l-proline-derived peptides.
Farrera-Sinfreu J; Giralt E; Castel S; Albericio F; Royo M
J Am Chem Soc; 2005 Jul; 127(26):9459-68. PubMed ID: 15984873
[TBL] [Abstract][Full Text] [Related]
23. Enhanced cellular delivery of cell-penetrating peptide-peptide nucleic acid conjugates by photochemical internalization.
Shiraishi T; Nielsen PE
Methods Mol Biol; 2011; 683():391-7. PubMed ID: 21053145
[TBL] [Abstract][Full Text] [Related]
24. On the mechanisms of the internalization of S4(13)-PV cell-penetrating peptide.
Mano M; Teodósio C; Paiva A; Simões S; Pedroso de Lima MC
Biochem J; 2005 Sep; 390(Pt 2):603-12. PubMed ID: 15907190
[TBL] [Abstract][Full Text] [Related]
25. Enhanced cell uptake of superparamagnetic iron oxide nanoparticles through direct chemisorption of FITC-Tat-PEG₆₀₀-b-poly(glycerol monoacrylate).
Wang C; Qiao L; Zhang Q; Yan H; Liu K
Int J Pharm; 2012 Jul; 430(1-2):372-80. PubMed ID: 22531849
[TBL] [Abstract][Full Text] [Related]
26. Creation of a novel cell penetrating peptide, using a random 18mer peptides library.
Nomura T; Kawamura M; Shibata H; Abe Y; Ohkawa A; Mukai Y; Sugita T; Imai S; Nagano K; Okamoto T; Tsutsumi Y; Kamada H; Nakagawa S; Tsunoda S
Pharmazie; 2007 Aug; 62(8):569-73. PubMed ID: 17867548
[TBL] [Abstract][Full Text] [Related]
27. A modified Tat peptide for selective intracellular delivery of macromolecules.
Murphy DJ; Walker B; Greer B; Harriott P; Martin SL
J Pharm Pharmacol; 2011 May; 63(5):611-8. PubMed ID: 21492162
[TBL] [Abstract][Full Text] [Related]
28. Oligonucleotide conjugation to a cell-penetrating (TAT) peptide by Diels-Alder cycloaddition.
Steven V; Graham D
Org Biomol Chem; 2008 Oct; 6(20):3781-7. PubMed ID: 18843408
[TBL] [Abstract][Full Text] [Related]
29. Human immunodeficiency virus type 1 Tat protein impairs selenoglutathione peroxidase expression and activity by a mechanism independent of cellular selenium uptake: consequences on cellular resistance to UV-A radiation.
Richard MJ; Guiraud P; Didier C; Seve M; Flores SC; Favier A
Arch Biochem Biophys; 2001 Feb; 386(2):213-20. PubMed ID: 11368344
[TBL] [Abstract][Full Text] [Related]
30. Reduction of doxorubicin resistance in P-glycoprotein overexpressing cells by hybrid cell-penetrating and drug-binding peptide.
Zheng Z; Aojula H; Clarke D
J Drug Target; 2010 Jul; 18(6):477-87. PubMed ID: 20088680
[TBL] [Abstract][Full Text] [Related]
31. Cellular uptake and lysosomal delivery of galactocerebrosidase tagged with the HIV Tat protein transduction domain.
Zhang XY; Dinh A; Cronin J; Li SC; Reiser J
J Neurochem; 2008 Feb; 104(4):1055-64. PubMed ID: 17986221
[TBL] [Abstract][Full Text] [Related]
32. Enhanced delivery of cell-penetrating peptide-peptide nucleic acid conjugates by endosomal disruption.
Shiraishi T; Nielsen PE
Nat Protoc; 2006; 1(2):633-6. PubMed ID: 17406290
[TBL] [Abstract][Full Text] [Related]
33. Cellular uptake of self-assembled cationic peptide-DNA complexes: multifunctional role of the enhancer chloroquine.
Yang S; Coles DJ; Esposito A; Mitchell DJ; Toth I; Minchin RF
J Control Release; 2009 Apr; 135(2):159-65. PubMed ID: 19171168
[TBL] [Abstract][Full Text] [Related]
34. Improved Tat-mediated plasmid DNA transfer by fusion to LK15 peptide.
Saleh AF; Aojula H; Arthanari Y; Offerman S; Alkotaji M; Pluen A
J Control Release; 2010 Apr; 143(2):233-42. PubMed ID: 20060860
[TBL] [Abstract][Full Text] [Related]
35. The global gene-expression profiles of U-937 human macrophages treated with Tat peptide and Tat-FITC conjugate.
Lin CW; Kuo JH; Jan MS
J Drug Target; 2012 Jul; 20(6):515-23. PubMed ID: 22632162
[TBL] [Abstract][Full Text] [Related]
36. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes.
Kuai R; Yuan W; Qin Y; Chen H; Tang J; Yuan M; Zhang Z; He Q
Mol Pharm; 2010 Oct; 7(5):1816-26. PubMed ID: 20701288
[TBL] [Abstract][Full Text] [Related]
37. Biological activity of Tat (47-58) peptide on human pathogenic fungi.
Jung HJ; Park Y; Hahm KS; Lee DG
Biochem Biophys Res Commun; 2006 Jun; 345(1):222-8. PubMed ID: 16678135
[TBL] [Abstract][Full Text] [Related]
38. Cellular uptake on N- and C-termini conjugated FITC of Rath cell penetrating peptides and its consequences for gene-expression profiling in U-937 human macrophages and HeLa cervical cancer cells.
Kuo JH; Lin CW
J Drug Target; 2013 Nov; 21(9):801-8. PubMed ID: 23937069
[TBL] [Abstract][Full Text] [Related]
39. Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain.
Shiraishi T; Nielsen PE
Methods Mol Biol; 2011; 751():209-21. PubMed ID: 21674333
[TBL] [Abstract][Full Text] [Related]
40. Photochemically enhanced cellular delivery of cell penetrating peptide-PNA conjugates.
Shiraishi T; Nielsen PE
FEBS Lett; 2006 Feb; 580(5):1451-6. PubMed ID: 16460737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
